Markets » Mutual Funds » Asset Allocation

Reliance Pharma Fund - Direct (D) - Scheme Profile

Fund

Fund House : Reliance Mutual Fund

Fund Class : Equity - Pharma

NAV 24 May 2017 59.63 -1.01
(-1.67%)

Asset Type

Asset Allocation
Cash & Cash Equivalent 0.00
CBLO 0.27
Equity 99.37
Net CA & Others 0.36
Equity Sector No. of Shares Mkt Value % of Assets Stocks Return
Asset / Company Name     (Rs cr)   Last 3 Mths
Cadila Health. Pharmaceuticals - Indian - Bulk Drugs & Fo... 3,200,000 140.88 10.29 -0.78
Aurobindo Pharma Pharmaceuticals - Indian - Bulk Drugs & Fo... 2,050,000 124.38 9.09 -21.13
Abbott India Pharmaceuticals - Multinational 270,001 119.45 8.73 -8.85
Sanofi India Pharmaceuticals - Multinational 253,207 106.16 7.76 -2.14
Dr Reddy's Labs Pharmaceuticals - Indian - Bulk Drugs & Fo... 400,871 104.19 7.61 -15.75
Sun Pharma.Inds. Pharmaceuticals - Indian - Bulk Drugs & Fo... 1,550,350 99.52 7.27 -12.35
› More

Sector Allocation

You can check out the sectoral allocation of the investments made for that scheme by the mutual fund in this Piechart as on the date selected.

Sector Name
Finance & Investments 4.75
Healthcare 7.02
Miscellaneous 6.80
NA 0.63
Pharmaceuticals - Indian - Bulk Drugs 13.99
Pharmaceuticals - Indian - Bulk Drugs & Formln 50.32
Pharmaceuticals - Multinational 16.49

Top Holdings

You can check out the Top Holdings of the investments made for that scheme by the mutual fund in
this Piechart as on the date selected.

Company Name
Abbott India 8.73
Apollo Hospitals 1.58
Aurobindo Pharma 9.09
Cadila Health. 10.29
Cipla 6.52
Divi's Lab. 7.14
Dr Reddy's Labs 7.61
Glenmark Pharma. 4.25